Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression

Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression

US Patent 10039764 · Granted Aug 7, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of therapeutically treating cancer2025
Derivatives of sulindac can protect normal cells against oxidative damage2023
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2022
Method of treating or preventing Ras-mediated diseases2021
Derivatives of sulindac can protect normal cells against oxidative damage2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Method of treating or preventing Ras-mediated diseases2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2020
Method of selectively inhibiting Ras-mediated tumor growth in humans2018
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2018